MiR-466 as a poor prognostic predictor suppresses cell proliferation and EMT in breast cancer cells by targeting PSMA7

Eur Rev Med Pharmacol Sci. 2022 Jun;26(11):3799. doi: 10.26355/eurrev_202206_28946.

Abstract

The article "MiR-466 as a poor prognostic predictor suppresses cell proliferation and EMT in breast cancer cells by targeting PSMA7, by Y. Xiao, S.-J. Zhang, X. Yan, C. Wu, Q.-W. Liu, H.-X. Dong, L.-J. Wang, Y. Hu, published in Eur Rev Med Pharmacol Sci 2021; 25 (18): 5625-5635-DOI: 10.26355/eurrev_202109_26782-PMID: 34604955" has been retracted by the authors as they state that some data cannot be repeated by further experiments. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/26782.

Publication types

  • Retraction of Publication

MeSH terms

  • Breast Neoplasms* / genetics
  • Cell Proliferation
  • Female
  • Humans
  • MicroRNAs* / genetics
  • Prognosis
  • Proteasome Endopeptidase Complex

Substances

  • MIRN466 microRNA, human
  • MicroRNAs
  • PSMA7 protein, human
  • Proteasome Endopeptidase Complex